The gene expression analysis of triple KO mouse tumors and human PCa patient samples with these mutations revealed altered expressions of E2F target genes and neuroendocrine lineage genes, together with increased expressions of stemness and epigenetic reprogramming-related genes, such as SOX2 and EZH2 [189,190]. This evidence concerns the gene EZH2 and posterior cortical atrophy.